Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001481 · ClinicalTrials.gov registry record · Phase 2

The Role of Hormones in Postpartum Mood Disorders

A Phase 2 study of Postpartum Depression, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
Phase 2
Development phase
74
Enrollment target
1
Study location

NCT00001481 is a Phase 2 study of Postpartum Depression that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 74 participants, below the 533-participant average among 38 other Postpartum Depression trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001481, a Phase 2 study of Postpartum Depression, has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
Phase 2
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The present protocol is designed to create a "scaled-down" hormonal milieu of pregnancy and the puerperium in order to determine whether it is the abrupt withdrawal of gonadal steroids or the prolonged exposure to gonadal steroids that is associated with mood symptoms.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Progesterone
  • DRUG Estradiol
  • DRUG leuprolide acetate

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 1996-04-26
Est. Completion 2024-10-25
Phase Phase 2

What the Registry Record Tells You About NCT00001481

The ClinicalTrials.gov registry entry for NCT00001481 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 533-participant average among 38 other Postpartum Depression trials with a reported enrollment target (86% lower). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT00001481 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001481 about?

NCT00001481 is a clinical study titled "The Role of Hormones in Postpartum Mood Disorders". The present protocol is designed to create a "scaled-down" hormonal milieu of pregnancy and the puerperium in order to determine whether it is the abrupt withdrawal of gonadal steroids or the prolonged exposure to gonadal steroids that is associated with mood symptoms.

What is the current status of trial NCT00001481?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 1996-04-26. Estimated completion is 2024-10-25.

What conditions does trial NCT00001481 study?

This clinical trial studies the following conditions: Postpartum Depression.

What interventions are being tested in trial NCT00001481?

The interventions under investigation include: Placebo (OTHER), Progesterone (DRUG), Estradiol (DRUG), leuprolide acetate (DRUG).

Who is sponsoring clinical trial NCT00001481?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001481 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.